If they are knocking back a De Novo application (probably the easiest path to get through), you really have to ask what are the issues here.
Is the product Not similar to an existing product already approved?
Ann: Update on US FDA De Novo Classification Request, page-7
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 311 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)